Tag: Axicabtagene ciloleucel

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Axicabtagene ciloleucel

US regulators unveil internal materials related to fought-over go-ahead for Biogen's Aduhelm in AD

Added to Collection on: 2021-06-23 17:48:45

Tags for this article:

Health sciences
Health
Medical research
Orphan drugs
Breakthrough therapy
Gilead Sciences
Biogen
Spinal muscular atrophy
Axicabtagene ciloleucel
Myocarditis
Lymphoma
Pfizer

Click the tags to see associated articles and topics

View Article Details
Opinion: CAR T-Cell Therapy Remains a Promising Therapeutic Option Despite FDA Inquiry ...

Added to Collection on: 2023-12-06 01:04:06

Tags for this article:

Gene therapy
Immune system
Lymphoma
Gilead Sciences
T cells
CAR T cell
Immunotherapy
Axicabtagene ciloleucel
Multiple myeloma
Cytokine release syndrome
Diffuse large B-cell lymphoma
Brexucabtagene autoleucel

Click the tags to see associated articles and topics

View Article Details
FDA says cancer treatment CAR-T therapy may cause cancer itself - KTVH

Added to Collection on: 2024-01-24 19:56:17

Tags for this article:

Gilead Sciences
CAR T-cell therapy
Orphan drugs
Cancer treatments
Antineoplastic drugs
CAR T cell
Kite Pharma
Immunotherapy
CD19
Brexucabtagene autoleucel
Juno Therapeutics
Axicabtagene ciloleucel

Click the tags to see associated articles and topics

View Article Details
Simple Blood Protein Tests Predict Which Lymphoma Patients Are Most Likely to Have Poor ...

Added to Collection on: 2024-01-30 18:13:57

Tags for this article:

Cancer
Gilead Sciences
Immunotherapy
H. Lee Moffitt Cancer Center & Research Institute
University of Florida
Roswell Park Comprehensive Cancer Center
CAR T cell
Cancer treatment
Axicabtagene ciloleucel
Cellular adoptive immunotherapy
Lymphoma
Kite Pharma

Click the tags to see associated articles and topics

View Article Details
New Study Recommends Shorter, Flexible Monitoring After CAR T-Cell Therapy - CGTLive®

Added to Collection on: 2024-08-01 19:18:06

Tags for this article:

Antineoplastic drugs
CAR T-cell therapy
Orphan drugs
Cancer treatments
Lymphoma
Axicabtagene ciloleucel
CAR T cell
Lisocabtagene maraleucel
Tisagenlecleucel
Cytokine release syndrome
Diffuse large B-cell lymphoma
Cell therapy

Click the tags to see associated articles and topics

View Article Details
Long-Term Axi-Cel Data Shows Durable Outcomes, Elucidates Drivers of Nonrelapse Mortality

Added to Collection on: 2024-08-08 19:19:54

Tags for this article:

Gilead Sciences
Axicabtagene ciloleucel
CAR T-cell therapy
H. Lee Moffitt Cancer Center & Research Institute
CAR T cell
AXI
Lymphoma
Immunotherapy
Tumors of the hematopoietic and lymphoid tissues
Cancer
Kite Pharma

Click the tags to see associated articles and topics

View Article Details
Chimeric Antigen Receptor (CAR) T-Cell Therapy - Special Topics - US (Wave 3) | Clarivate

Added to Collection on: 2024-11-02 17:31:33

Tags for this article:

Gilead Sciences
Antineoplastic drugs
CAR T-cell therapy
Orphan drugs
Biotechnology
CAR T cell
Kite Pharma
Cancer immunotherapy
Axicabtagene ciloleucel
Tisagenlecleucel
Immunotherapy
Cell therapy
Novartis

Click the tags to see associated articles and topics

View Article Details
Physical Performance Predicts Outcomes in CAR T-Cell Therapy in NHL

Added to Collection on: 2025-02-19 00:05:26

Tags for this article:

Lymphoma
Antineoplastic drugs
CAR T-cell therapy
Orphan drugs
Gilead Sciences
Axicabtagene ciloleucel
CAR T cell
Adoptive cell transfer
Diffuse large B-cell lymphoma
Non-Hodgkin lymphoma
Tisagenlecleucel
Hodgkin lymphoma

Click the tags to see associated articles and topics

View Article Details
Study Finds Recent Falls, Inability to Balance on Left Leg Indicate OS Decrease in NHL

Added to Collection on: 2025-02-18 22:07:03

Tags for this article:

Lymphoma
Gilead Sciences
Cancer treatments
Axicabtagene ciloleucel
CAR T-cell therapy
CAR T cell
Non-Hodgkin lymphoma
Hodgkin lymphoma
Adoptive cell transfer
Draft:James N. Kochenderfer
Kite Pharma

Click the tags to see associated articles and topics

View Article Details
Biopharm Industry Impacts of FDA Eliminating REMS for CAR-T Therapies

Added to Collection on: 2025-06-30 17:21:41

Tags for this article:

CAR T-cell therapy
Orphan drugs
Antineoplastic drugs
Cancer treatments
Food and Drug Administration
CAR T cell
B-cell maturation antigen
Cell therapy
Axicabtagene ciloleucel
Risk Evaluation and Mitigation Strategies
Bristol-Myers Squibb
Lisocabtagene maraleucel

Click the tags to see associated articles and topics

View Article Details
Book a Demo